Western blot analysis revealed that a decrease in hPaf1/PD2 level in pancreatic cancer cells leads to a significant decrease (*p<0.05) in MLL1 protein level (Fig. 2A, S3). This evidence concerns the gene PAF1 and familial pancreatic carcinoma.